Abstract
Cancer is often viewed as a primary disturbance of cell division. One might, therefore, expect to find the critical alterations exclusively in the nucleus of the malignant cells. Interestingly, however, many of the products of cancer-inducing viral genes-so called oncogenes-have now been traced to the periphery of the cell, namely, the plasma membrane. Furthermore, several of these viral oncogenes appear to be derived from cellular genes that code for products active at the periphery of the cell: these include growth factors, their membrane-bound receptors, and membrane-associated enzymes (Newmark, 1982). Cell biologists and developmental biologists have, of course, argued for years that the cell surface is a major component in the control of growth, differentiation, and movement of cells (Moscona, 1974) and that alterations of cell surface molecules are likely to be critically important in the establishment of malignant behavior. Immunologic probes have an extreme sensitivity for discovering even very subtle alterations in a surface molecule that change a normal “self” molecule to an abnormal “altered-self” molecule. Immunologic analysis of the tumor cell surface might, therefore, be extremely useful for discovering cell surface changes that are important for causing malignant behavior of the cell.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abelev, G. I. 1968, Production of embryonal serum α globulin by hepatomas. Review of experimental and clinical data, Cancer Res. 28: 1344.
Bailey, D. W., 1982, How pure are inbred strains of mice, Immunol. Today 3: 210.
Barbacid, M., 1984, Molecular and cellular biology, in: Genes and Cancer UCLA Symposia, New Series, Vol. 17, Alan R. Liss, New York pp. 353–373.
Bartlett, P. F., and Edidin, M., 1978, Effect of the H-2 gene complex rates of fibroblast intracellular adhesion, J. Cell Biol 77: 377
Basombrío, M. A., 1970, Search for common antigenicities among twenty-five sarcomas induced by methylcholanthrene, Cancer Res. 30: 2458.
Basombrío, M. A., and Prehn, R. T., 1972, Studies on the basis for diversity and time of appearance of antigens in chemically induced tumors, Natl. Cancer Inst. Monogr. 35: 117.
Bernards, R., Schrier, P. I., Houweling, A., Bos, J. L., Van der Eb, A. J., Zijstra, M., and Melief, C. J. M., 1983, Tumorigenicity of cells transformed by adenovirus type 12 by evasion of T cell immunity, Nature 305: 776.
Bodmer, W. F., 1973, A new genetic model for allelism at histocompatibility and other complex loci. Polymorphism for control of gene expression, Transplant. Proc. 5: 1471.
Bortin, M. M., and Truitt, R. L. (eds.), 1980, 1st International Symposium on Alien Histocompatibility Antigens on Cancer Cells, Transplant. Proc. 12: 1.
Bortin, M. M., and Truitt, R. L. (eds.), 1981, 2nd International Symposium on Alien Histocompatibility Antigens on Cancer Cells, Transplant. Proc. 13: 1751.
Bowen, J. G., and Baldwin, R. W., 1975, Tumor-specific antigens related to rat histocompatibility antigens, Nature 258: 75.
Boyse, E. A., 1970, Cell membrane receptors, in: Immunosurveillance (R. T. Smith and M. Landy, eds.), Academic Press, New York, London, pp. 5–48.
Burnet, F. M., 1970, A certain symmetry: Histocompatibility antigens compared with immune receptors, Nature 226: 124.
Callahan, G. N., Pardi, D., Giedlin, M. A., Allison, J. P., Morizot, D. M., and Martin, W. J., 1983, Biochemical evidence for the expression of a semiallogeneic, H-2 antigen by a murine adenocarcinoma, J. Immunol. 130: 471.
Curtis, A. S. G., 1979, Histocompatibility systems, recognition and cell positioning, Dev. Comp. Immunol. 3: 379.
Curtis, A. S. G., and Rooney, P. 1979, H-2 restriction of contact inhibition of epithelial cells, Nature 281: 222.
Daynes, R. A., and Spellman, C. W., 1977, Evidence for the generation of suppressor cells by ultraviolet radiation, Cell. Immunol. 31: 182.
Downward, J., Yarden, Y., Hayes, E., Scrace, G., Totty, N., Stockwell, P., Ullrich, A., Schlessinger, J., and Waterfield, M. D., 1984, Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences, Nature 307: 521.
Edidin, M., 1983, MHC antigens and nonimmune functions, Immunol. Today 4: 269.
Embleton, M. J., and Heidelberger, C., 1972, Antigenicity of clones of mouse prostate cells transformed in vitro, Int. J. Cancer 9: 8.
Evan, G. I., Lennox, E. S., Alderson, E. S., and Croft, L., 1983, A monoclonal anti-HLA antibody recognizes a mouse tumor associated antigen, Eur. J. Immunol. 13: 160.
Farber, E., 1973, Carcinogenesis cellular evolution as a unifying thread, Cancer Res. 33: 2537.
Festenstein, H., and Schmidt, W., 1981, Variation in MHC antigenic profiles of tumor cells and its biological effects, Immunol. Rev. 60: 85.
Fisher, M. S., and Kripke, M. L., 1978, Systemic alteration induced by mice by ultraviolet light irradiation and its relationship to ultraviolet carcinogenesis, Proc. Natl. Acad. Sci. U.S.A. 74: 1688.
Flaherty, L, and Rinchik, E., 1978, No evidence for foreign H-2 specificities on the EL4 mouse lymphoma, Nature 273: 52.
Flood, P. M., Kripke, M. L., Rowley, D. A., and Schreiber, H., 1980, Suppression of tumor rejection by antologous anti-idiotypic immunity, Proc. Natl. Acad. Sci. U.S.A. 77: 2209.
Flood, P. M., Urban, J. L., Kripke, M. L., and Schreiber, H., 1981, Loss of tumor-specific and anti-idiotypic immunity with age, J. Exp. Med. 154: 275.
Flood, P. M., DeLeo, A. B., Old, L. J., and Gershon, R. K., 1983, Relation of cell surface antigens on methylcholanthrene-induced fibrosarcomas to immunoglobulin heavy chain complex variable region-linked T cell interaction molecules, Proc. Natl. Acad. Sci. U.S.A. 80: 1683.
Foley, E. J., 1953, Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin, Cancer Res. 13: 835.
Foulds, L., 1954, The experimental study of tumor progression: A review, Cancer Res. 14: 327.
Garrido, F., Festenstein, H., and Schirrmacher, V., 1976, Further evidence for derepression of H-2 and la like specificities of foreign haplotypes in mouse tumor cell lines, Nature 261: 705.
Gold, P., and Freedman, S. O., 1976, Specific carcinoembryonic antigens of the human digestive system, J. Exp. Med. 122: 467.
Gross, L., 1943, Intradermal immunization of C3H mice against a sarcoma that originated in an animal of the same line, Cancer Res. 3: 326.
Hood, L., Steinmetz, M., and Malissen, B., 1983, Genes of the major histocompatibility complex of the mouse, Annu. Rev. Immunol. 1: 529.
Invernizzi, G., and Parmiani, G., 1975, Tumor-associated transplantation antigens of chemically induced sarcoma cross-reactivity with allogeneic histocompatibility antigens, Nature 254: 713.
Klein, G., Sjögren, H. O., Klein, E., and Hellström, K. E., 1960, Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host, Cancer Res. 20: 1561.
Klein, J., 1982, The science of self-nonself discrimination, in: Immunology, John Wiley & Sons, New York.
Klein, J., and Fiqueroa, F., 1981, Polymorphism of the mouse H-2 loci, Immunol. Rev. 60: 23.
Kripke, M. L., 1974, Antigenicity of murine skin tumors induced by ultraviolet light, J. Natl. Cancer Inst 53: 1333.
Kripke, M. L., 1981, Immunologic mechanisms in UV radiation carcinogenesis, Adv. Cancer Res. 34: 69.
Kripke, M. L., and Fisher, M. S., 1976, Immunologic parameters of ultraviolet carcinogenesis, J. Natl. Cancer Inst. 57: 211.
Lampson, L. A., and Levy, R., 1979, A role for clonal antigens in cancer diagnosis and therapy, J. Natl. Cancer Inst. 62: 217.
Lennox, E. S., Lowe, A. D., Cohn, J., and Evan, G., 1981, Specific antigens on methyl- cholanthrene-induced tumors of mice, Transplant. Proc. 13: 1759.
Moscona, A. A. (ed.), 1974, The Cell Surface in Development, John Wiley & Sons, New York.
Müller, R., Slamon, D. J., Tremblay, J. M., Cline, M. J., and Verma, I. M., 1982, Differential expression of cellular oncogenes during pre- and postnatal development of the mouse, Nature 299: 640.
Newmark, P., 1984, Cell and cancer biology meld, Nature 307: 499.
Nowell, P. C., 1976, The clonal evolution of tumor cell populations. Acquired genetic lability permits selection of variant sublines and underlies tumor progression, Science 194: 23.
Nowinski, R. C., Stone, M. R., Tam, M. R., Lostrom, M. E., Burnette, M. N., and O’- Donnell, P. V., 1980, Mapping of viral proteins with monoclonal antibodies, analysis of the envelope proteins of murine leukemia viruses, in: Monoclonal Antibodies ( R. H. Kennett, T. J. McKearn, and K. B. Bechtol, eds.), Plenum Press, New York, London, pp. 295–315.
Old, L. J., 1982, Cancer immunology: The search for specificity, Natl. Cancer Inst. Monogr. 60: 193.
Parmiani, G., Carbone, G., Invernizzi, G., Pierotti, M. A., Sensi, M. L., Rogers, M. J., and Appella, E., 1979, Alien histocompatibility antigens on tumor cells, Immunogenetics 9: 1.
Philipps, C., McMillan, M., Flood, P. M., Murphy, D. B., Forman, J., Lancki, D., Womack, J. E., Goodenow, R. S., and Schreiber, H., 1985, Identification of a unique tumor- specific antigen as a novel class I major histocompatibility molecule, Proc. Natl. Acad. Sei. U.S.A. 82: 5140.
Pinter, A., Honnen, W. J., Tung, J. S., O’Donnell, P. V., and Hämmerling, U., 1982, Structural domains of endogenous murine leukemia virus gp 70s containing specific antigenic determinants defined by monoclonal antibodies, Virology 116: 499.
Pravtcheva, D. D., DeLeo, A. B., Ruddle, F. H., and Old, L. J., 1981, Chromosome assignment of the tumor-specific antigen of a 3-methylcholanthrene-induced mouse sarcoma, J. Exp. Med. 154: 964.
Prehn, R. T., and Main, J. M., 1957, Immunity to methylcholanthrene-induced sarcomas, J. Natl. Cancer Inst. 18: 769.
Reddy, E. P., Reynolds, R. K., Santos, E., and Barbacid, M., 1983, A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene, Nature 300: 149.
Roman, J. M., Hirsch, J., Readhead, C., Levy, D., DeOgny, L., and Dreyer, W. J., 1981, Heritable differences among gp 70-like molecules on C3H ultraviolet light-induced fibrosarcomas, Transplant. Proc. 13: 1782.
Rous, P., and Beard, J. W., 1935, The progression to carcinoma of virus-induced rabbit papillomas (Shope), J. Exp. Med. 62: 523.
Schmidt, W., and Festenstein, H., 1980, Serological and immunochemical studies on H-2 allospecificities on K36, a syngeneic tumor of AKR, J. Immunogenet. 7: 7.
Schreiber, A. B., Schlessinger, J., and Edidin, M., 1984, Interaction between major histocompatibility complex antigens and epidermal growth factor receptors on human cells, J. Cell Biol. 98: 725.
Schreiber, H., 1984, Idiotype-specific interactions in tumor immunity, Adv. Cancer Res. 41: 291–321.
Schrier, P. I., Bernards, R., Vaessen, R. T. M. J., Houweling, A., and Van der Eb, A. J., 1984, Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells, Nature 305: 771.
Simonson, M., and Olsson, L., 1983, Possible roles of compound membrane receptors in the immune system, Ann. Immunol. 134D: 85.
Sondel, P. M., and Bach, F. H., 1980, The alienation of tumor immunity. Alien-driven diversity and alien-selected escape, Transplant. Proc. 12: 211.
Spellman, C. W., and Daynes, R. A., 1978, Immunoregulation by ultraviolet light. III. Enhancement of suppressor cell activity in older animals, Exp. Gerontol. 13: 141.
Steinmetz, M., Moore, K. W., Frelinger, J. G., Sher, B. T., Shen, F. W., Boyse, E. A., and Hood, L., 1981, A pseudogene homologous to mouse transplantation antigens: Transplantation antigens are encoded by light exons that correlate with protein domains, Cell 25: 683.
Steinmetz, M., Winoto, A., Minard, K., and Hood, L., 1982, Clusters of genes encoding mouse transplantation antigens, Cell 28: 489.
Tabin, C. J., Bradley, S. M., Bargmann, C. I., Weinberg, R. A., Papageorge, A. G. Scolnick, E. M., Dhar, R., Lowly, D. R., and Chang, E. H., 1982, Mechanism of activation of a human oncogene, Nature 300: 143.
Travers, P. J., Arklie, J. L., Trowsdale, J., Patillo, R. A., and Bodmer, W. F., 1982, Lack of expression of HLA-ABC antigens in choriocarcinoma and other human tumor cell lines, Natl. Cancer Inst. Monogr. 60: 175.
Urban, J. L., and Schreiber, H., 1984, Rescue of the tumor-specific immune response of aged mice in vitro, J. Immunol. 133: 527.
Urban, J. L., Burton, R. C., Holland, J. M., Kripke, M. L., and Schreiber, H., 1982a, Mechanisms of syngeneic tumor rejection: Susceptibility of host-selected progressor variants to various immunological effector cells, J. Exp. Med. 155: 557.
Urban, J. L., Holland, J. M., Kripke, M. L., and Schreiber, H., 1982b, Immunoselection of tumor cell variants by mice suppressed with ultraviolet radiation, J. Exp. Med. 156: 1025.
Urban, J. L., Van Waes, C., and Schreiber, H., 1984, Pecking order among tumor-specific antigens, Eur. J. Immunol. 14: 18.
Uyttenhove, C., Maryanski, J., and Boon, T., 1983, Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen loss variants rather than immunosuppression, J. Exp. Med. 157: 1040.
Weinberg, R. A., 1982, Fewer and fewer oncogenes, Cell, 30: 3.
Woglom, W. H., 1929, Immunity to transplantable tumors, Cancer Rev. 4: 129.
Wortzel, R. D., Philipps, C., and Schreiber, H., 1983a, Multiplicity of unique tumor-specific antigens expressed on a single malignant cell, Nature 304: 165.
Wortzel, R. D., Philipps, C., Urban, J. L., Fitch, F. W., and Schreiber, H., 1983b, Independent immunodominant and immunorecessive tumor-specific determinants on a malignant tumor. Antigenic dissection with cytolytic T cell clones, J. Immunol. 130: 2461.
Wortzel, R. D., Urban, J. L., and Schreiber, H., 1984, Malignant growth in the normal host after variant selection in vitro with cytolytic T cell lines, Proc. Natl. Acad. Sci. U.S.A. 81: 2186.
Zeleny, V., Matousëk, V., and Lengerovâ, A., 1978, Intercellular adhesiveness of H-2 identical and H-2 disparate cells, J. Immunogenet. 5: 41.
Zinkernagel, R. M., and Doherty, P. C., 1979, MHC-restricted cytotoxic cells: Studies on the biological role of the polymorphic major transplantation antigens determining T cell restriction specificity function and responsiveness, Adv. Immunol. 27: 51.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Plenum Press, New York
About this chapter
Cite this chapter
Schreiber, H., van Waes, C., Stauss, H.J. (1985). Unique Tumor-Specific Antigens as Altered Cell-Surface Receptors. In: Poste, G., Crooke, S.T. (eds) Mechanisms of Receptor Regulation. New Horizons in Therapeutics. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2131-6_19
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2131-6_19
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9259-3
Online ISBN: 978-1-4613-2131-6
eBook Packages: Springer Book Archive